{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:00:20Z","timestamp":1793638820890,"version":"4.5.1"},"reference-count":21,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Early recurrence (ER) following curative-intent surgery for pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis. Identifying preoperative risk factors for ER is essential for optimizing perioperative strategies. This study aimed to investigate perioperative predictors of ER, with a specific focus on tumor localization. Methods: We retrospectively analyzed 163 patients who underwent R0 or R1 resection for PDAC. ER was defined as recurrence within 6 months postoperatively. Two separate multivariate logistic regression analyses were conducted: one including only preoperative variables, and one including both pre- and postoperative factors. Results: ER occurred in 35.6% of patients and was associated with significantly worse overall survival (median 9 vs. 21 months, p &lt; 0.001) and post-recurrence survival (5 vs. 8 months, p = 0.008). Preoperative ECOG performance status &gt; 0 (OR 3.31, p = 0.013) and CA 19-9 &gt; 208 U\/mL (OR 3.18, p = 0.022) were identified as independent predictors of ER. In the postoperative model, tumor localization in the body\/tail (OR 3.23, p = 0.035), tumor size &gt; 3.25 cm, lymph node ratio &gt; 0.13, and absence of adjuvant therapy were also significant. Notably, tumor location did not influence overall survival. Conclusions: Tumor localization in the body\/tail of the pancreas is independently associated with early recurrence but not overall survival. These findings highlight the importance of incorporating tumor site into preoperative risk stratification and support the consideration of neoadjuvant therapy in select anatomically resectable patients, particularly those with left-sided tumors.<\/jats:p>","DOI":"10.3390\/medicina61101799","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:42:49Z","timestamp":1759750969000},"page":"1799","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Tumor Localization on Early Recurrence After Curative Resection in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0785-0238","authenticated-orcid":false,"given":"Eda","family":"Caliskan Yildirim","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9124-6123","authenticated-orcid":false,"given":"Ilkay Tugba","family":"Unek","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Oztop","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8596-4233","authenticated-orcid":false,"given":"Mehmet","family":"Uzun","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarkan","family":"Unek","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"},{"name":"Department of Pathology, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgul","family":"Sagol","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir 35340, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","article-title":"Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma","volume":"269","author":"Groot","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.pan.2014.09.006","article-title":"Optimal duration of the early and late recurrence of pancreatic cancer after pancreatectomy based on the difference in the prognosis","volume":"14","author":"Yamamoto","year":"2014","journal-title":"Pancreatology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1245\/s10434-021-10866-6","article-title":"Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma","volume":"29","author":"Ishido","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.21037\/atm.2019.08.35","article-title":"A combination of platelet-to-lymphocyte ratio and carbohydrate antigen 19-9 predict early recurrence after resection of pancreatic ductal adenocarcinoma","volume":"7","author":"Ikuta","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Suto, H., Okano, K., Oshima, M., Ando, Y., Takahashi, S., Shibata, T., Kamada, H., Kobara, H., Masaki, T., and Suzuki, Y. (2019). The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: The influence of pre- and post- operative adjuvant therapy. BMC Surg., 19.","DOI":"10.1186\/s12893-019-0644-z"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12957-023-03141-3","article-title":"Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection","volume":"21","author":"Murakawa","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pan.2015.09.008","article-title":"Proposed preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after surgical resection: A multi-center retrospective study","volume":"15","author":"Matsumoto","year":"2015","journal-title":"Pancreatology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sung, M.K., Park, Y., Kwak, B.J., Jun, E., Lee, W., Song, K.B., Lee, J.H., Hwang, D.W., and Kim, S.C. (2021). Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111706"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1002\/bjs.10772","article-title":"Defining the molecular pathology of pancreatic body and tail adenocarcinoma","volume":"105","author":"Dreyer","year":"2018","journal-title":"Br. J. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1245\/s10434-024-15105-2","article-title":"Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a \u201cBiological R2 Definition\u201d","volume":"31","author":"Belfiori","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPA.0b013e3181bd6489","article-title":"Incidence and Survival of Pancreatic Head and Body and Tail Cancers: A Population-Based Study in the United States","volume":"39","author":"Lau","year":"2010","journal-title":"Pancreas"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Birnbaum, D.J., Bertucci, F., Finetti, P., Birnbaum, D., and Mamessier, E. (2019). Head and Body\/Tail Pancreatic Carcinomas Are Not the Same Tumors. Cancers, 11.","DOI":"10.3390\/cancers11040497"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100771","DOI":"10.1016\/j.esmoop.2022.100771","article-title":"Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Rother","year":"2023","journal-title":"ESMO Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.21.02233","article-title":"Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial","volume":"40","author":"Versteijne","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.annonc.2022.09.161","article-title":"Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)\u2014A randomized phase II trial of the AIO pancreatic cancer group","volume":"34","author":"Seufferlein","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.annonc.2024.12.015","article-title":"The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: An international multicenter study","volume":"36","author":"Rangelova","year":"2025","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pan.2017.11.011","article-title":"International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017","volume":"18","author":"Isaji","year":"2018","journal-title":"Pancreatology"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Imamura, M., Nagayama, M., Kyuno, D., Ota, S., Murakami, T., Kimura, A., Yamaguchi, H., Kato, T., Kimura, Y., and Takemasa, I. (2021). Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer. Cancers, 13.","DOI":"10.3390\/cancers13102285"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10147-012-0474-9","article-title":"Performance status of patients is the major prognostic factor at all stages of pancreatic cancer","volume":"18","author":"Tas","year":"2013","journal-title":"Int. J. Clin. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1799\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T12:25:12Z","timestamp":1759753512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":21,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["medicina61101799"],"URL":"https:\/\/doi.org\/10.3390\/medicina61101799","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}